BTMD · biote Corp.
$2.32
+0.05 (+1.98%)
At close · Jul 27
Market Cap
$85.69M
Shares
37.58M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Program Authorized
$20,000,000
as of 2024-01-24
Remaining Authorization
$18,500,000
as of 2026-03-31
Program Utilization
7.5%
$1,500,000 used of $20,000,000
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2026-03-31 YTD | $1,071,000 | 10-Q, filed 2026-05-11 |
| 2025-12-31 | $3,365,000 | 10-K, filed 2026-03-13 |
| 2024-12-31 | $5,599,000 | 10-K, filed 2026-03-13 |